Literature DB >> 13276592

Metabolism and excretion of 14C-labelled diethylcarbamazine.

D R BANGHAM.   

Abstract

Entities:  

Keywords:  PIPERAZINES/metabolism; URINE

Mesh：

Substances：

Year:  1955        PMID： 13276592      PMCID： PMC1509538          DOI： 10.1111/j.1476-5381.1955.tb00093.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  6 in total

1.  The mode of action of diethylcarbamazine investigated with 14C-labelled drug.

Authors:  D R BANGHAM
Journal:  Br J Pharmacol Chemother       Date:  1955-12

2.  The effect of cobalamin on the quantitative utilization of serine, glycine and formate for the synthesis of choline and methyl groups of methionine.

Authors:  H R ARNSTEIN; A NEUBERGER
Journal:  Biochem J       Date:  1953-09       Impact factor: 3.857

3.  Study of precursors of formate in the intact rat.

Authors:  S WEINHOUSE; B FRIEDMANN
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

4.  Effect of choline and cystine on the oxidation of the methyl group of methionine.

Authors:  C G MACKENZIE; V DU VIGNEAUD
Journal:  J Biol Chem       Date:  1952-04       Impact factor: 5.157

5.  The mode of action of hetrazan on filarial worms.

Authors:  F HAWKING; P SEWELL; J P THURSTON
Journal:  Br J Pharmacol Chemother       Date:  1950-06

6.  Determination of hetrazan in biological fluids.

Authors:  M LUBRAN
Journal:  Br J Pharmacol Chemother       Date:  1950-06
  6 in total
  8 in total

1.  The mode of action of diethylcarbamazine investigated with 14C-labelled drug.

Authors:  D R BANGHAM
Journal:  Br J Pharmacol Chemother       Date:  1955-12

2.  A simple helium-ethanol flow counter for monitoring chromatograph-column effluents containing weak beta-emitting isotopes.

Authors:  D R BANGHAM
Journal:  Biochem J       Date:  1956-04       Impact factor: 3.857

Review 3.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

4.  Experimental filariasis of Dipetalonema dessetae in Proechimys oris: 3. Effects of parasitism on the pharmacokinetics of diethylcarbamazine.

Authors:  F Kani; P Gayral; M C Pfaff-Dessales; G Mahuzier; C Jacquot; J L Auget
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Oct-Dec       Impact factor: 2.441

5.  Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.

Authors:  J Anderson; H Fuglsang
Journal:  Br J Ophthalmol       Date:  1978-07       Impact factor: 4.638

6.  The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man.

Authors:  K K Adjepon-Yamoah; G Edwards; A M Breckenridge; M L Orme; S A Ward
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  [Experimental filariasis in Proechimys oris by Dipetalonema dessetae. 5. Effect of parasitism on metabolism of diethylcarbamazine].

Authors:  F Kani; M C Dessalles; C Jacquot; G Mahuzier; P Gayral
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jul-Sep       Impact factor: 2.441

8.  Inhibition by diethylcarbamazine (hetrazan) of the eosinophil response which trichina extract elicits in guinea-pig lymph nodes.

Authors:  O I Thevathasan; M Litt
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.